PlainPharmaWatch
CMS PY 2024 Company profile Open Payments data

PIRAMAL CRITICAL CARE

PIRAMAL CRITICAL CARE reported $111.6K in payments to physicians and teaching hospitals across 444 transactions in CMS Open Payments PY 2024.

Pharmaceutical payment transparency data for PIRAMAL CRITICAL CARE. Ranked #1082 of 1,797 companies by total payments. Source: CMS Open Payments, Program Year 2024.

Payment Overview

Total Payments

$111.6K

0.0% of all payments

Transactions

444

$251.35 avg

Recipients

444

$251.35 avg

Industry Rank

#1082

of 1,797 companies

What the Data Shows for PIRAMAL CRITICAL CARE

In Program Year 2024, PIRAMAL CRITICAL CARE reported $111,599.13 in payments to 444 physicians and teaching hospitals across 444 individual transactions — an average of $251.35 per transaction and $251.35 per recipient. That total places PIRAMAL CRITICAL CARE at rank #1082 out of 1,797 companies in the CMS Open Payments database, representing 0.0% of all industry payments reported nationwide for the year. Payment volume at this scale is characteristic of manufacturers with broad prescriber engagement, active clinical research programs, or patented therapies generating ongoing royalty obligations.

The payment mix for PIRAMAL CRITICAL CARE spans 3 distinct categories defined by CMS — including general payments (consulting, speaker fees, meals, travel), research payments tied to clinical trials, and ownership or investment interests. The largest single category is "Compensation for Services Other Than Consulting" at $85.6K, accounting for 76.7% of the company's reported total and 31 transactions. This distribution matters because different payment types carry different regulatory and ethical implications: research funding supports clinical development, while general payments like meals and speaker fees have been studied for their correlation with prescribing patterns in peer-reviewed journals such as JAMA Internal Medicine.

Recipient concentration is another useful lens. The top 5 recipients of payments from PIRAMAL CRITICAL CARE received $0.00 combined — 0.0% of the company's total — with the remaining 100.0% distributed across the rest of the 444 recipients. A relatively distributed top-5 share suggests broader engagement across the prescriber community rather than concentration among a handful of high-value relationships. All figures above are drawn directly from the CMS Open Payments Public Use Files for PY2024 and are disclosed under the Physician Payments Sunshine Act; this page summarizes reported financial transfers and does not represent medical advice or judgment about individual prescribing decisions.

Payment Breakdown by Type

PIRAMAL CRITICAL CARE made 3 types of payments. "Compensation for Services Other Than Consulting" accounts for 76.7%.

Compensation for Services Other Than Consulting $85.6K

76.7% · 31 transactions

Food and Beverage $14.8K

13.3% · 339 transactions

Travel and Lodging $11.2K

10.0% · 74 transactions

Payment Type Amount Transactions
Compensation for Services Other Than Consulting $85.6K 31
Food and Beverage $14.8K 339
Travel and Lodging $11.2K 74

Payment Size Analysis

Average transaction size: $251.35. Average per recipient: $251.35.

Total Amount

$111,599.13

Avg per Transaction

$251.35

Avg per Recipient

$251.35

Payment Transparency Context

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.3B

across 1,797 companies

PIRAMAL CRITICAL CARE Share

0.0%

#1082 by total payments

Frequently Asked Questions

How much did PIRAMAL CRITICAL CARE pay to physicians and hospitals in 2024?
PIRAMAL CRITICAL CARE made $111,599.13 in payments to physicians and hospitals in Program Year 2024, across 444 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from PIRAMAL CRITICAL CARE?
PIRAMAL CRITICAL CARE made payments to 444 physicians and teaching hospitals in 2024. The average payment per recipient was $251.35.
What types of payments did PIRAMAL CRITICAL CARE make?
PIRAMAL CRITICAL CARE made 3 different types of payments. The largest category was "Compensation for Services Other Than Consulting" at $85.6K, representing 76.7% of all payments.
How does PIRAMAL CRITICAL CARE rank among pharmaceutical companies?
PIRAMAL CRITICAL CARE ranks #1082 out of 1,797 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from PIRAMAL CRITICAL CARE?
The average transaction from PIRAMAL CRITICAL CARE was $251.35 in 2024. The company made 444 total transactions to 444 recipients.
Are the top recipients concentrated for PIRAMAL CRITICAL CARE?
The top 5 recipients received $0.00 from PIRAMAL CRITICAL CARE, representing 0.0% of the company's total payments. Payments are relatively well-distributed across recipients.
Where does the payment data for PIRAMAL CRITICAL CARE come from?
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.3B across 1,797 companies.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.